Literature DB >> 20346412

Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii-derived heat shock protein 70 gene.

Akitoshi Kikumura1, Hao Fang, Hye-Seong Mun, Noriko Uemura, Masayuki Makino, Yusuke Sayama, Kazumi Norose, Fumie Aosai.   

Abstract

Toxoplasma gondii-derived heat shock protein 70 (T.g.HSP70) was proven to induce lethal anaphylactic reaction in T. gondii-infected mice through platelet-activating factor (PAF)-mediated, but not classical IgE-dependent, pathway via TLR4/MyD88 signal pathway. The effector cells generating PAF and causing T.g.HSP70-induced anaphylactic reaction were CD11b(+) and CD11c(+) cells, although the reaction was enhanced by marked IFN-gamma production by CD11b(+), CD11c(+), CD4(+) and CD8(+) splenocytes. In the present study, the effects of T.g.HSP70 gene vaccine targeting peripheral dendritic cells were evaluated against T.g.HSP70-induced anaphylactic reaction in T. gondii-infected mice. C57BL/6 mice receiving T.g.HSP70 gene vaccine showed prolonged survival. Platelets of peripheral blood, which completely disappeared during the T.g.HSP70-induced anaphylactic reaction, were partially restored with the T.g.HSP70 gene vaccination. The T.g.HSP70-induced marked production of PAF and IFN-gamma from splenocytes of infected mice during the T.g.HSP70-induced anaphylactic reaction was shown to decrease after the T.g.HSP70 gene vaccination. Thus, T.g.HSP70 gene vaccine induced protective immunity against T.g.HSP70-induced PAF-mediated lethal anaphylactic reaction in T. gondii-infected mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346412     DOI: 10.1016/j.parint.2010.03.006

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  6 in total

1.  Toxoplasma gondii infection inhibits Th17-mediated spontaneous development of arthritis in interleukin-1 receptor antagonist-deficient mice.

Authors:  Takuya Washino; Masataka Moroda; Yoichiro Iwakura; Fumie Aosai
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

2.  The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice.

Authors:  Mona M El Temsahy; Eman D H El Kerdany; Maha M Eissa; Thanaa I Shalaby; Iman M Talaat; Nermine M F H Mogahed
Journal:  J Parasit Dis       Date:  2014-09-05

3.  Interleukin-17A-Deficient Mice Are Highly Susceptible to Toxoplasma gondii Infection Due to Excessively Induced T. gondii HSP70 and Interferon Gamma Production.

Authors:  Masataka Moroda; Masaya Takamoto; Yoichiro Iwakura; Jun Nakayama; Fumie Aosai
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

4.  Immunization of C57BL/6 Mice with GRA2 Combined with MPL Conferred Partial Immune Protection against Toxoplasma gondii

Authors:  Jalal Babaie; Samira Amiri; Robab Homayoun; Ebrahim Azimi; Reyhaneh Mohabati; Mahboobe Berizi; M. Reza Sadaie; Majid Golkar
Journal:  Iran Biomed J       Date:  2017-06-25

5.  Recombinant TgHSP70 Immunization Protects against Toxoplasma gondii Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression.

Authors:  Paulo Czarnewski; Ester C B Araújo; Mário C Oliveira; Tiago W P Mineo; Neide M Silva
Journal:  Front Cell Infect Microbiol       Date:  2017-04-25       Impact factor: 5.293

6.  Global Proteomic Analysis of Lysine Malonylation in Toxoplasma gondii.

Authors:  Lan-Bi Nie; Qin-Li Liang; Rui Du; Hany M Elsheikha; Nai-Jian Han; Fa-Cai Li; Xing-Quan Zhu
Journal:  Front Microbiol       Date:  2020-04-28       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.